share_log

Barrington Research Maintains Outperform on Imax, Maintains $24 Price Target

Benzinga ·  Apr 25 15:16

Barrington Research analyst James Goss maintains Imax (NYSE:IMAX) with a Outperform and maintains $24 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment